2024 annual financial data

ProQR Therapeutics 2024 Net margin

Direct answer

Net margin was -146.86%.

Operating income was -30.47M EUR and net income was -27.76M EUR.
Operating cash flow was -36.39M EUR.

Get free ProQR Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
18.91M EUR
Operating income
-30.47M EUR
Net income
-27.76M EUR
Operating cash flow
-36.39M EUR